Four Forces Disrupting DSO Growth in 2026: PE, AI, Integration, and Diagnostics

DSOs in 2026 face four disruptors reshaping competitive strategy across the dental sector. Private equity investment is resurging — oral surgery is the only dental specialty that avoided a PE deal decline last year, recording a 9.1% increase according to Pitchbook. Medical-dental integration is accelerating, with organizations like PDS Health partnering with CareQuest Innovation Partners on in-office blood pressure screenings and deploying Epic-integrated care across medical, dental, and ambulatory settings. Artificial intelligence is driving efficiency gains in diagnostics, patient trust-building, and operational workflows across major DSO networks. And salivary diagnostics are emerging as a new standard of care — enabling DSOs to position their clinicians as oral physicians managing systemic health. Together, these forces are redefining competitive advantage for DSO executives evaluating capital allocation and strategic partnerships in 2026.